(Q67490923)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1319868%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

title

Pharmacokinetics of temafloxacin in patients with liver impairment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1319868%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

Pharmacokinetics of Temafloxacin in Patients with Liver Impairment† (English)

1 reference

10.2165/00003088-199200221-00006

Crossref

DOI

https://api.crossref.org/works/10.2165/00003088-199200221-00006

6 December 2023

1 reference

G. R. Granneman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

G. Mahr

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

C. Locke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

P. Nickel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

W. Kirch

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

W. Fabian

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

M. Kinzig

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

K. G. Naber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

F. Sörgel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1319868

13 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1319868

13 September 2022

publication date

1 January 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1319868%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

14 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1319868%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

volume

22 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1319868%20AND%20SRC:MED&resulttype=core&format=json

14 September 2019

page(s)

24-32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1319868%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003088-199200221-00006

14 September 2019

exact match

0 references

cites work

Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Effect of Cimetidine on the Pharmacokinetics of Temafloxacin

1 reference

12 December 2020

Pharmacokinetics of Temafloxacin after Multiple Oral Administration

1 reference

12 December 2020

Pharmacokinetics of temafloxacin in humans after single oral doses

1 reference

12 December 2020

Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin in elderly subjects

1 reference

12 December 2020

Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years

1 reference

12 December 2020

Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study

1 reference

12 December 2020

Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis

1 reference

12 December 2020

In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin in liver cirrhosis

1 reference

12 December 2020

Comparative antibacterial activities of temafloxacin hydrochloride (A-62254) and two reference fluoroquinolones

1 reference

12 December 2020

Comparative in vitro activity of the new difluoro-quinolone temafloxacin (A-62254) against bacterial isolates from cancer patients.

1 reference

12 December 2020

1 reference

12 December 2020

Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis

1 reference

12 December 2020

The effect of age on the pharmacokinetics of enoxacin

1 reference

12 December 2020

Temafloxacin pharmacokinetics in subjects with normal and impaired renal function

1 reference

12 December 2020

Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers

1 reference

12 December 2020

In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.

1 reference

12 December 2020

Hepatobiliary Elimination of Temafloxacin†

1 reference

12 December 2020

Effect of Antacid Medication on the Pharmacokinetics of Temafloxacin

1 reference

12 December 2020

Pharmacokinetics of ciprofloxacin in young (healthy volunteers) and elderly patients, and concentrations in prostatic fluid, seminal fluid, and prostatic adenoma tissue following intravenous administration

1 reference

12 December 2020

10.2165/00003088-199200221-00006

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1319868%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

14 September 2019

0 references

1 reference